Wall Street analyst price targets, ratings consensus & upside potential · Updated May 1, 2026
Last 12 months price action with 12-month analyst target path
As of May 6, 2026, Mondelez International, Inc. (MDLZ) has a Wall Street consensus price target of $67.00, based on estimates from 41 covering analysts. With the stock currently trading at $61.87, this represents a potential upside of +8.3%. The company has a market capitalization of $79.42B.
Analyst price targets range from a low of $61.00 to a high of $73.00, representing a 18% spread in expectations. The median target of $67.00 aligns closely with the consensus average. The tight target dispersion indicates high conviction among analysts.
The current analyst consensus rating is Buy, with 31 analysts rating the stock as a Buy or Strong Buy,8 rating it Hold, and 2 rating it Sell or Strong Sell. This overwhelmingly bullish sentiment suggests analysts see significant catalysts for upside ahead.
From a valuation perspective, MDLZ trades at a trailing P/E of 32.7x and forward P/E of 20.2x. Analysts expect EPS to grow +51.2% over the next year.
Our proprietary valuation model, which blends historical multiples with forward estimates, suggests a base-case price target of $101.41, with bear and bull scenarios of $69.16 and $184.13 respectively. Model confidence stands at 67/100, reflecting moderate uncertainty in projections.
Analyst consensus, bull case, AI-generated risk factors, and peer comparison — all in one place.
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorDCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationSide-by-side business, growth, and profitability comparison vs Walmart Inc..
Start ComparisonQuick answers to the most common questions about buying MDLZ stock.
The consensus price target for MDLZ is $67, close to the current price of $61.87 (8.3% implied move). Based on 41 analyst estimates, the stock appears fairly valued near current levels.
MDLZ has a consensus rating of "Buy" based on 41 Wall Street analysts. The rating breakdown is predominantly bullish, with 31 Buy/Strong Buy ratings. The consensus 12-month price target of $67 implies 8.3% upside from current levels.
MDLZ trades at a forward P/E of 20.2395x, representing a moderate valuation. With analysts targeting $67 (8.3% implied move), the stock appears reasonably valued with upside.
The most bullish Wall Street analyst has a price target of $73 for MDLZ, while the most conservative target is $61. The consensus of $67 represents the median expectation. Our quantitative valuation model projects a bull case target of $184 based on optimistic growth and margin assumptions. These targets typically reflect 12-month expectations.
MDLZ is heavily covered by Wall Street, with 41 analysts providing price targets and ratings. Of these, 0 have Strong Buy ratings, 31 have Buy ratings, 8 recommend Hold, and 2 have Sell or Strong Sell ratings. Higher analyst coverage generally indicates greater institutional interest and more reliable consensus estimates.
The 12-month MDLZ stock forecast based on 41 Wall Street analysts shows a consensus price target of $67, with estimates ranging from $61 (bear case) to $73 (bull case). The median consensus rating is "Buy". Our proprietary valuation model produces a base case fair value of $101, with bear/bull scenarios of $69/$184.
Our quantitative valuation model calculates MDLZ's fair value at $101 (base case), with a bear case of $69 and bull case of $184. The model uses discounted cash flow analysis, historical growth rates, and margin mean-reversion to project FY+2 earnings, then applies an appropriate P/E multiple. The model confidence score is 67/100.
MDLZ trades at a forward P/E ratio of 20.2x based on next-twelve-months earnings estimates compared to a trailing P/E of 32.7x. The lower forward P/E indicates analysts expect earnings growth. A forward P/E is useful for comparing valuations when earnings are expected to change significantly.
MDLZ appears fairly valued according to analysts, with a "Buy" rating and minimal upside to the $67 target. Consider your investment thesis and risk tolerance. This information is for educational purposes only. Always conduct your own research, consider your financial situation, and consult a financial advisor before making investment decisions.
MDLZ analyst price targets range from $61 to $73, a 18% tight range reflecting strong analyst consensus. Differences stem from varying assumptions about revenue growth, profit margins, competitive dynamics, and valuation multiples. The $67 consensus represents the middle ground. Our model's $69-$184 range provides an independent fundamental perspective.